NP+PA Perspectives in Dermatology: December 2023

Click the cover to access the full digital edition of NP+PA Perspectives in Dermatology, December 2023

J Clin Aesthet Dermatol. 2023;16(12 Suppl 2)

NP+PA Perspectives in Dermatology: December 2023

Life and Career Coaching for NPs and PAs: Navigating New Horizons: Exploring the Top 5 Reasons PAs and NPs Pursue Career Changes
by Kasey D’Amato PA-C

Dermatological Conditions in Skin of Color– Diagnosing and Treating Rosacea in Skin of Color Patients
by Archana M. Sangha, MMS, PA-C

Healthcare Provider Administration of Biologics for Patients with Plaque Psoriasis: Literature Review and Clinical Considerations
by Matthew Brunner, MHS, PA-C, DFAAPA; Keri Holyoak, MPH, MSHS, PA-C;
and Douglas DiRuggiero, DMSc, MHS, PA-C

Pearls from the Scope—What Your Dermatopathologist Wants You to Know: Direct immunofluorescence
by Maria R. Robinson, MD, MBA, FAAD

Regular Exercise Improved Fatigue and Musculoskeletal Pain in Young Adult Patients with Psoriasis without Psoriatic Arthritis
by Antonio J. Diaz, Miguel A. Rosety, Jose C. Armario, Manuel J. Bandez, Natalia Garcia-Gomez, Eduardo Sanchez-Sanchez,
Jara Diaz, Cristina Castejon-Riber, Marco Bernardi, Manuel Rosety-Rodriguez M, Francisco J. Ordonez, and Ignacio Rosety

Share:

Recent Articles:

Christopher Bunick, MD, PhD, and James Del Rosso, DO: Clindamycin Phosphate 1.2%/Adapalene 0.15%/Benzoyl Peroxide 3.1% to Treat Acne Induced by Janus Kinase Inhibitor Treatment: A Case Report
Diego Ruiz Dasilva, MD: Nemolizumab Demonstrates Marked Efficacy in Challenging Chronic Pruritus: A Real-world Multicenter Case
Letters to the Editor: September 2025
Hidradenitis Suppurativa Patients Experience a Significant Musculoskeletal Symptom Burden: A Quality Improvement Initiative Using the IDEOM MSK-Q
Remission of Alopecia Areata Post-colectomy in a Patient with Crohn's Disease
1 2 3 338

Categories:

Recent Articles:

Peter Lio, MD: Updates in AD and Diet
Christopher Bunick, MD, PhD, and James Del Rosso, DO: Clindamycin Phosphate 1.2%/Adapalene 0.15%/Benzoyl Peroxide 3.1% to Treat Acne Induced by Janus Kinase Inhibitor Treatment: A Case Report
Diego Ruiz Dasilva, MD: Nemolizumab Demonstrates Marked Efficacy in Challenging Chronic Pruritus: A Real-world Multicenter Case
Letters to the Editor: September 2025
Hidradenitis Suppurativa Patients Experience a Significant Musculoskeletal Symptom Burden: A Quality Improvement Initiative Using the IDEOM MSK-Q
Remission of Alopecia Areata Post-colectomy in a Patient with Crohn's Disease
What Are Topical Adaptogens? A Systematic Review and Proposed System to Identify and Categorize Skin Adaptogens in Dermatology
Clindamycin Phosphate 1.2%/Adapalene 0.15%/Benzoyl Peroxide 3.1% to Treat Acne Induced by Janus Kinase Inhibitor Treatment: A Case Report
Nemolizumab Demonstrates Marked Efficacy in Challenging Chronic Pruritus: A Real-world Multicenter Case Series
Availability of Hats Online in the United States that Meet Sun Protective Recommendations
1 2 3 209

Tags: